EPIX

ESSA Pharma
EPIX

Overview Fund Trends Analyst Outlook
Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

46 hedge funds and large institutions have $58.8M invested in ESSA Pharma in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+14
Holders Change %
+43.75%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
24
Increased
8
Reduced
5
Closed
10
Calls
$179K
Puts
$55K
Net Calls
+$124K
Net Calls Change
+$228K

Top Buyers

1
TCM
Tang Capital Management
California
+$7.7M
2
BCM
BML Capital Management
Indiana
+$7.56M
3
OM
Opaleye Management
Massachusetts
+$3.96M
4
ACM
Altium Capital Management
New York
+$2.56M
5
Bank of America
Bank of America
North Carolina
+$1.45M

Top Sellers

1
BG
Bellevue Group
Switzerland
-$47.8M
2
PHS
PFM Health Sciences
California
-$16.6M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.93M
4
RPAM
Rhenman & Partners Asset Management
Sweden
-$4.88M
5
RSCM
Rock Springs Capital Management
Maryland
-$4.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
RSCM
51
Rock Springs Capital Management
Maryland
– -$4.1M -677,005 Closed
PHP
52
Parkman Healthcare Partners
Connecticut
– -$2.1M -345,902 Closed
CIBC World Market
53
CIBC World Market
Ontario, Canada
– -$446K -73,587 Closed
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
– -$382K -62,955 Closed
KCM
55
Kennedy Capital Management
Missouri
– -$249K -41,092 Closed
Simplex Trading
56
Simplex Trading
Illinois
– -$31K -5,162 Closed
1 2
3